January 2023 FDA Recall Drug by Nephron Sterile Compounding Center Llc
D-0099-2023 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Nephron Sterile Compounding Center Llc on January 6, 2023 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0099-2023

Reason for Recall
Lack of Assurance of Sterility
Initiated
01-06-2023
Reported
01-18-2023
Quantity
38,830 syringes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nephron Sterile Compounding Center LLC
Nationwide in the USA.
Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-924-05

Batch or Lot Expiration Information

Lot# Lot: RC2011A, Exp. 2/22/2023